The Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc.

BPDCN is an aggressive hematologic malignancy with a historically poor prognosisVisualDx is a clinical decision support system used by more than ...

An expert discusses how medical professionals have integrated tagraxofusp into blastic plasmacytoid dendritic cell neoplasm (BPDCN) treatment, leveraging its CD123-targeted efficacy per 0114 trial ...

An expert discusses how, historically, blastic plasmacytoid dendritic cell neoplasm (BPDCN) was treated with regimens for acute leukemia or lymphoma. Current NCCN guidelines recommend intensive ...

Phyllodes tumors, varying from benign to malignant, need precise diagnosis and surgery, with a focus on multidisciplinary ...

Veteran firefighters appear to have a higher risk of brain tumors called gliomas, which can be caused by gene mutations ...

MANILA, Philippines — Heart diseases, neoplasms and stroke were the top three causes of death in the country from January to August of 2024, according to the Philippine Statistics Authority (PSA).

Ischaemic heart diseases, neoplasms and cerebrovascular diseases were the top three causes of death in the country from January to August of 2024, according to the Philippine Statistics Authority (PSA ...

Myeloproliferative neoplasms are a group of rare blood cancers that affect the bone marrow leading to abnormal cell growth that can lead to an increase in the number of red blood cells, white blood ...